About
Indexeli is built by an operator who has had to make the market decisions himself.
I am Peter Langdon, founder of Indexeli. My background combines regulated healthcare operations, provider-level market building, M&A opportunity scoping, pipeline building and target ranking.
Why this matters
The work sits between data, commercial judgement and real operating constraints.
Indexeli is not built around abstract market reports. It comes from the practical problem of deciding which markets are real, which providers matter, which routes are credible and which opportunities deserve time, capital or outreach.
That judgement is shaped by running a regulated healthcare business, building direct-to-patient digital health products, and years of corporate development work where the job was to identify markets, build pipelines, rank targets and decide where effort should go.
Relevant experience.
The credibility is a combination: regulated healthcare operator, finance discipline, and hands-on market and deal opportunity building.
Regulated healthcare operator
Co-founder, Finance and Operations Director of Berkshire Aesthetics, a CQC-registered, doctor-led private medical clinic led by Dr Selena Langdon. The clinic was named UK Aesthetics Awards Clinic of the Year 2026 and has been featured in Tatler.
Built from zero
Built the commercial, financial, operational and governance infrastructure around a regulated clinic, including CQC authorisation, premises, prescribing operations, supplier relationships, data protection and patient acquisition.
Regulatory context
First-hand experience navigating CQC, MHRA advertising rules for prescription-only medicines, ASA healthcare advertising standards, UK GDPR and ICO obligations.
Market and deal scoping
Corporate development and M&A roles across PE-backed, FTSE-listed and international groups, focused on scoping market opportunities, identifying deal opportunities, building pipelines and ranking targets.
Finance and corporate development
Fellow Chartered Accountant and Oxford MBA, with experience across IPO workstreams, investor relations, corporate finance, financial modelling, budgeting and transaction support.
Indexeli founder
Founder of Indexeli Intelligence, building provider-level datasets, pricing benchmarks, launch-route intelligence and market maps for self-pay healthcare, aesthetics, beauty, wellness and care markets.
Corporate development background.
Before building Indexeli and operating in private healthcare, Peter worked on corporate development, M&A, IPO and investor-facing projects for larger groups. That experience shapes how Indexeli scopes markets, builds pipelines and ranks opportunities for smaller operators and suppliers.
Biffa plc
Head of Corporate Development and Investor Relations during Biffa's transition from PE-backed ownership to a premium LSE listing. Work included IPO workstreams, equity story, prospectus input, analyst materials and investor-relations setup.
Vue International
Corporate development work in a PE-backed international cinema group, supporting market and opportunity assessment in a multi-country operating environment.
Rubix Group
Interim corporate development in an Advent-backed MRO distributor, working with commercial and country teams on growth, acquisition and strategic opportunities.
DS Smith plc
Corporate development support in a FTSE 250 packaging business, contributing to M&A and strategic projects across a larger listed-company environment.
Orascom Construction
Managed acquisition and investment analysis work, including structuring, funding, opportunity assessment and negotiations on large international transactions.
Corporate finance foundation
Earlier roles in corporate finance, turnaround and advisory, plus founding a transaction-support boutique, built the discipline around evidence, value drivers, opportunity ranking and deal execution.
How it shows up
The offer is deliberately practical.
- Market-entry work starts with the decision, not a generic market overview.
- Provider data is used to rank where adoption, pricing power or commercial fit is strongest.
- Target lists are treated as pipelines that need qualification, not spreadsheets to exhaust.
- Founder-led clinics can be supported with buyer logic, transaction readiness and acquisition pipeline ranking before a formal process begins.
- Pricing and adoption evidence is source-linked so it can hold up in buyer, investor or board-level discussion.
- Regulated-market constraints are treated as commercial facts, not footnotes.
Contact
Talk to Indexeli.
Send the market, category or opportunity you are trying to assess. I will tell you whether Indexeli can help and what a useful first readout would look like.